2 patient evaluations for Levetiracetam with a adherence rating of Never taken as prescribed

21 members have decided to share their profiles only with other members of PatientsLikeMe.

Jul 22, 2016 (Started Feb 05, 2009)

  • Effectiveness
    Slight (for osteoporosis)
  • Effectiveness
    Major (for epilepsy)
  • Side effects
    None
  • Adherence
    Never taken as prescribed
  • Burden
    A little hard to take
Dosage: 3000 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Nov 9, 2008 (Started Sep 03, 2007)

  • Effectiveness
    Can't tell (for epilepsy)
  • Side effects
    None
  • Adherence
    Never taken as prescribed
  • Burden
    Very hard to take
Advice & Tips: Don't even start taking it.
Cost: $50-99 monthly
Side effects: balance problems, eyes wander out of sync, glaucoma (both eyes)

Nov 9, 2007 (Started Sep 03, 2007)

  • Effectiveness
    Can't tell (for epilepsy)
  • Side effects
    Severe (eyes wander out of sync, balance problems)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 500 mg Daily
Advice & Tips: Do not even start with Keppra
Cost: $50-99 monthly
Side effects: balance problems, eyes wander out of sync, glaucoma (both eyes)

Nov 8, 2007 (Started Sep 03, 2007)

  • Effectiveness
    Can't tell (for epilepsy)
  • Side effects
    Severe (balance problems)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 100 mg Daily
Advice & Tips: When they gave me the initial level to start taking it I had no side effects that I was aware of. I was told it was a dosage belwo therapeutic and after 2 weeks they increased it. By the second day my eyes would not function together. I saw 2 images and it was like the eyes were just wandering around to look at things randomly and continuously. The 2 were not in synch at all and I had no sense of balance to even sit up in a chair without holding on to a desk or something.
Cost: $50-99 monthly
Side effects: balance problems, eyes wander out of sync, glaucoma (both eyes)

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Levetiracetam